FOR IMMEDIATE RELEASE :
March 25, 2020
Contact: Doug Curley
(781) 647-3700 ext. 1570
DCurley@novabio.com
Waltham, MA– Nova Biomedical is pleased to announce the launch of the Stat EMS Basic blood testing system for ambulance and emergency care in CE mark countries. Stat EMS Basic measures fingerstick capillary lactate, glucose, ketone, hemoglobin, and hematocrit in six to 40 seconds with laboratory-quality results.
Stat EMS Basic is a smaller, non-connectivity version of Nova’s connectivity-capable Stat EMS system with the same test menu. Stat EMS Basic combines battery-operated StatStrip Xpress2 meters in a new, lightweight soft case that easily fits in a medic’s bag while holding all system components: meters, test strips, controls, and lancets. Test strips and controls require no refrigeration, making testing convenient and economical.
Specifically designed for ambulance, pre-hospital, and emergency use, Stat EMS Basic provides an important test menu and rapid results to aid with patient assessment and allow for faster, more effective emergency treatment. Stat EMS Basic also assists with rapid triage and determining the appropriate transport site for patients who have trauma, sepsis, anemia, acute coronary syndrome, or other critical illnesses.
Stat EMS Basic meters use Nova’s patented, disposable test strips that provide lab-like accuracy, including the only lactate test strip cleared for fingerstick testing and the only glucose test strip proven accurate enough to have been cleared by the U.S. Food and Drug Administration for use with critically ill patients—and used in thousands of hospitals worldwide.
Stat EMS Basic meters are easy to use; there is no calibration or coding and the testing procedure is as simple as fingerstick glucose testing performed by people with diabetes. Tiny capillary samples eliminate the need for venipuncture, saving time and reducing costs.
“We at Nova Biomedical are thrilled to introduce Stat EMS Basic to CE mark countries, and offer Stat EMS’s proven critical care testing technology in a compact model for ambulance and emergency providers without connectivity needs,” said Doug Curley, Global Sales Product Line Manager at Nova. “Stat EMS Basic represents the latest in pre-hospital testing and continues to demonstrate Nova’s worldwide leadership in critical care and point-of-care testing.”
About Nova Biomedical
Incorporated in 1976 and based in Waltham, MA, Nova Biomedical is a world leader in the development and manufacturing of state-of-the-art, whole blood point-of-care and critical care analyzers, as well as the most advanced instruments for cell culture monitoring in the biotechnology market. Nova is one of the fastest growing in vitro diagnostic companies in the world. Nova’s biosensor technology is incorporated in products ranging from handheld meters for glucose self- and point-of-care testing to critical care whole blood analyzers designed for rapid measurement of over 20 analytes. Nova’s biotechnology-specific BioProfile line has pioneered comprehensive cell culture testing, providing over 16 critical cell culture tests with 12 unique instrument offerings for a broad range of cell culture applications. Nova employs over 1,300 people worldwide and has wholly owned subsidiaries located in Brazil, Canada, France, Germany, Great Britain, Italy, Japan, Spain, and Switzerland.
www.novabiomedical.com